PortfoliosLab logo

Inovio Pharmaceuticals, Inc. (INO)

Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US45773H2013
CUSIP
45773H201

INOPrice Chart


Chart placeholderClick Calculate to get results

INOPerformance

The chart shows the growth of $10,000 invested in Inovio Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $16,477 for a total return of roughly 64.77%. All prices are adjusted for splits and dividends.


INO (Inovio Pharmaceuticals, Inc.)
Benchmark (S&P 500)

INOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M5.99%0.43%
6M-4.23%9.37%
YTD-18.08%22.33%
1Y-30.22%26.59%
5Y-1.15%15.74%
10Y13.54%14.46%

INOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

INOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Inovio Pharmaceuticals, Inc. Sharpe ratio is -0.36. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


INO (Inovio Pharmaceuticals, Inc.)
Benchmark (S&P 500)

INODividends


Inovio Pharmaceuticals, Inc. doesn't pay dividends

INODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


INO (Inovio Pharmaceuticals, Inc.)
Benchmark (S&P 500)

INOWorst Drawdowns

The table below shows the maximum drawdowns of the Inovio Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Inovio Pharmaceuticals, Inc. is 87.11%, recorded on Oct 1, 2019. It took 160 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.11%Mar 20, 20141394Oct 1, 2019160May 20, 20201554
-80.34%Jun 30, 2020220May 13, 2021
-75.66%Jan 18, 2011231Dec 14, 2011406Jul 30, 2013637
-57.67%Aug 6, 201311Aug 20, 2013127Feb 21, 2014138
-47.65%Mar 5, 2010124Aug 30, 201095Jan 13, 2011219
-24.76%May 21, 202010Jun 4, 202013Jun 23, 202023
-23.08%Jan 15, 201010Jan 29, 201011Feb 16, 201021
-11.8%Feb 27, 20142Feb 28, 201413Mar 19, 201415
-6.47%Feb 17, 20102Feb 18, 20102Feb 22, 20104
-6.42%Jul 31, 20131Jul 31, 20131Aug 1, 20132

INOVolatility Chart

Current Inovio Pharmaceuticals, Inc. volatility is 41.81%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


INO (Inovio Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Inovio Pharmaceuticals, Inc.


Loading data...

More Tools for Inovio Pharmaceuticals, Inc.